Granahan Investment Management - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 87 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2018$260,000
+32.0%
80,257
-1.9%
0.02%
+63.6%
Q3 2018$197,000
-13.6%
81,849
+0.2%
0.01%
-21.4%
Q2 2018$228,000
-31.9%
81,693
+15.8%
0.01%
-41.7%
Q1 2018$335,00070,5340.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 722,890$911,0000.53%
GREAT POINT PARTNERS LLC 3,500,000$4,410,0000.44%
NEA Management Company, LLC 5,556,778$7,002,0000.36%
SECTORAL ASSET MANAGEMENT INC 2,050,328$2,583,0000.31%
HARBOURVEST PARTNERS LLC 440,627$555,0000.20%
VHCP Management II, LLC 427,110$538,0000.16%
Endurant Capital Management LP 130,600$165,0000.06%
ALGERT GLOBAL LLC 64,300$81,0000.05%
Bain Capital Public Equity Management, LLC 231,418$292,0000.03%
Kazazian Asset Management, LLC 14,436$18,0000.02%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders